scholarly journals Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection

Author(s):  
Rudragouda Channappanavar ◽  
Stanley Perlman
2020 ◽  
Vol 13 (11) ◽  
Author(s):  
Franca del Nonno ◽  
Andrea Frustaci ◽  
Romina Verardo ◽  
Cristina Chimenti ◽  
Emanuele Nicastri ◽  
...  

Intervirology ◽  
2006 ◽  
Vol 50 (2) ◽  
pp. 71-77 ◽  
Author(s):  
Apiradee Theamboonlers ◽  
Rujipat Samransamruajkit ◽  
Chittima Thongme ◽  
Alongkorn Amonsin ◽  
Voranush Chongsrisawat ◽  
...  

2020 ◽  
Author(s):  
Shahan Mamoor

The coronavirus COVID19 pandemic is an emerging biosafety threat to the nation and the world (1). There are no treatments approved for coronavirus infection in humans (2) and there is a lack of information available regarding the basic transcriptional behavior of human cells and mammalian tissues following coronavirus infection. We mined two independent datasets (3, 4), public (3) and published (4) containing transcriptome data from infection models of the Middle East respiratory syndrome (MERS) coronavirus and human coronavirus (HCoV) to discover genes that are differentially expressed in coronaviruses and identify potential therapeutic targets and host cell vulnerabilities. We identified the La ribonucleoprotein domain family member 6 (LARP6) as a conserved differentially expressed gene following coronavirus infection. LARP6 may be involved in the cellular response to COVID19 infection.


2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Wayne Vuong ◽  
Muhammad Bashir Khan ◽  
Conrad Fischer ◽  
Elena Arutyunova ◽  
Tess Lamer ◽  
...  

Abstract The main protease, Mpro (or 3CLpro) in SARS-CoV-2 is a viable drug target because of its essential role in the cleavage of the virus polypeptide. Feline infectious peritonitis, a fatal coronavirus infection in cats, was successfully treated previously with a prodrug GC376, a dipeptide-based protease inhibitor. Here, we show the prodrug and its parent GC373, are effective inhibitors of the Mpro from both SARS-CoV and SARS-CoV-2 with IC50 values in the nanomolar range. Crystal structures of SARS-CoV-2 Mpro with these inhibitors have a covalent modification of the nucleophilic Cys145. NMR analysis reveals that inhibition proceeds via reversible formation of a hemithioacetal. GC373 and GC376 are potent inhibitors of SARS-CoV-2 replication in cell culture. They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals. The work here lays the framework for their use in human trials for the treatment of COVID-19.


2015 ◽  
Vol 2 (suppl_1) ◽  
Author(s):  
Monique Bouvier ◽  
John Arnold ◽  
Wei-Ju Chen ◽  
Mary Fairchok ◽  
Christina Schofield ◽  
...  

2020 ◽  
Author(s):  
Shahan Mamoor

The coronavirus COVID19 pandemic is an emerging biosafety threat to the nation and the world (1). There are no treatments approved for coronavirus infection in humans (2) and there is a lack of information available regarding the basic transcriptional behavior of human cells and mammalian tissues following coronavirus infection. We mined independent published (3-5) and public (6) datasets, containing transcriptome data from infection models of the human coronavirus 229E and of severe acute respiratory syndrome (SARS) coronavirus to discover genes that are differentially expressed in coronaviruses and identify potential therapeutic targets and host cell vulnerabilities. We identified IL6 and IL1RN as conserved differentially expressed genes following coronavirus infection. IL6 and IL1RN may be involved in the cellular response to COVID19 infection.


2020 ◽  
Author(s):  
Shahan Mamoor

We mined published and public microarray datasets (1-6) to discover conserved host cell machinery transcriptionally modulated by the coronavirus family. We found significant differential expression and transcriptional repression of a gene utilized during de novo purine synthesis, PAICS, following infection of human cells with the Middle East Respiratory Syndrome (MERS) coronavirus in vitro, in the lungs of mice following infection with the Severe Acute Respiratory Syndrome (SARS) coronavirus 1 (SARS-CoV-1), in the blood and lungs of ferrets following intranasal infection with SARS-CoV-1, but not in human cells infected with the human coronavirus HCoV-229E. These data indicate transcriptional modulation of de novo purine synthesis pathways by viruses of the coronavirus family or during coronavirus infection.


2020 ◽  
Author(s):  
Shahan Mamoor

Co-infection is a process by which a cell or organism already infected with a virus is then infected with a second, different virus (1, 2). The human coronavirus SARS-CoV-2 has resulted in the death of nearly 200,000 Americans in less than one year (3, 4); the upcoming influenza could potentially pose a problem with respect to co-infection with Influenza and SARS-CoV-2; significant co-infection in patients with SARS-CoV-2 has been reported (5). We mined a published microarray dataset (6) to discover genes associated with viral co-infection in patients with a coronavirus infection. We found that genes of the HLA family, particularly HLA-DRB and HLA-A, were significantly differentially expressed in the blood of patients with human coronavirus infections, including HCoV-229E, HCoV OC43, HCoV NL63, and HCoV HKU1. Different viral co-infections, including Influenza A, Human Rhinovirus, Enterovirus, and Respiratory Syncytial Virus A co-infections were also associated with significant differential expression of HLA family genes in patient blood. Perturbation of HLA family gene expression appears to be a general feature of viral co-infection in humans.


2020 ◽  
Author(s):  
Shahan Mamoor

The coronavirus COVID19 pandemic is an emerging biosafety threat to the nation and the world (1). There are no treatments approved for coronavirus infection in humans (2) and there is a lack of information available regarding the basic transcriptional behavior of human cells and mammalian tissues following coronavirus infection. We mined two independent datasets (3, 4), public (3) and published (4) containing transcriptome data from infection models of the Middle East respiratory syndrome (MERS) coronavirus and human coronavirus (HCoV) to discover genes that are differentially expressed in coronaviruses and identify potential therapeutic targets and host cell vulnerabilities. We identified tribbles homolog 1, TRIB1 as a conserved differentially expressed gene following coronavirus infection. TRIB1 may be involved in the cellular response to COVID19 infection.


Sign in / Sign up

Export Citation Format

Share Document